Achieve Life Sciences
ACHV
39 hedge funds and large institutions have $18.6M invested in Achieve Life Sciences in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
225% more call options, than puts
Call options by funds: $1.37M | Put options by funds: $421K
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
26% more funds holding
Funds holding: 31 → 39 (+8)
12% more capital invested
Capital invested by funds: $16.6M → $18.6M (+$1.97M)
3.21% more ownership
Funds ownership: 13.78% → 16.99% (+3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
+$2.08M |
| 2 |
AIC
AWM Investment Company
New York
|
+$1.91M |
| 3 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$1.52M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.11M |
| 5 |
OGC
One68 Global Capital
New York
|
+$678K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$990K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$867K |
| 3 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$457K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$128K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$77.1K |
ACHV Hedge Fund Activity: Q2 2023 in Review
39 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2023, worth a combined $18.6M — up 12% from $16.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ACHV positions and 3 closed out — a net gain of 8 holders — while 14 added to existing stakes and 10 trimmed.
The largest buyer was Shay Capital, adding an estimated $2.08M. The largest seller was Ikarian Capital, exiting entirely with an estimated $990K sold.
- 39 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2023, up from 31 in Q1 2023.
- Funds reported $18.6M of Achieve Life Sciences stock for Q2 2023, up 12% quarter-over-quarter.
- 11 funds opened new Achieve Life Sciences positions in Q2 2023 and 3 closed out, a net change of +8 holders.
- The largest Achieve Life Sciences buyer in Q2 2023 was Shay Capital, an estimated $2.08M added.
- The largest Achieve Life Sciences seller in Q2 2023 was Ikarian Capital, an estimated $990K sold.
Based on aggregated 13F filings for Q2 2023.